123 related articles for article (PubMed ID: 37552151)
21. Technical Note: Treatment planning system (TPS) approximations matter - comparing intensity-modulated proton therapy (IMPT) plan quality and robustness between a commercial and an in-house developed TPS for nonsmall cell lung cancer (NSCLC).
Liu C; Yu NY; Shan J; Bhangoo RS; Daniels TB; Chiang JS; Ding X; Lara P; Patrick CL; Archuleta JP; DeWees T; Hu Y; Schild SE; Bues M; Sio TT; Liu W
Med Phys; 2019 Nov; 46(11):4755-4762. PubMed ID: 31498885
[TBL] [Abstract][Full Text] [Related]
22. Evaluating the Toxicity Reduction With Computed Tomographic Ventilation Functional Avoidance Radiation Therapy.
Faught AM; Miyasaka Y; Kadoya N; Castillo R; Castillo E; Vinogradskiy Y; Yamamoto T
Int J Radiat Oncol Biol Phys; 2017 Oct; 99(2):325-333. PubMed ID: 28871982
[TBL] [Abstract][Full Text] [Related]
23. Dosimetric comparison between 2-dimensional radiation therapy and intensity modulated radiation therapy in treatment of advanced T-stage nasopharyngeal carcinoma: to treat less or more in the planning organ-at-risk volume of the brainstem and spinal cord.
Chau RM; Teo PM; Kam MK; Leung SF; Cheung KY; Chan AT
Med Dosim; 2007; 32(4):263-70. PubMed ID: 17980826
[TBL] [Abstract][Full Text] [Related]
24. A novel four-dimensional radiotherapy planning strategy from a tumor-tracking beam's eye view.
Li G; Cohen P; Xie H; Low D; Li D; Rimner A
Phys Med Biol; 2012 Nov; 57(22):7579-98. PubMed ID: 23103415
[TBL] [Abstract][Full Text] [Related]
25. Use of 4-dimensional computed tomography-based ventilation imaging to correlate lung dose and function with clinical outcomes.
Vinogradskiy Y; Castillo R; Castillo E; Tucker SL; Liao Z; Guerrero T; Martel MK
Int J Radiat Oncol Biol Phys; 2013 Jun; 86(2):366-71. PubMed ID: 23474113
[TBL] [Abstract][Full Text] [Related]
26. Impact of Spot Size and Spacing on the Quality of Robustly Optimized Intensity Modulated Proton Therapy Plans for Lung Cancer.
Liu C; Schild SE; Chang JY; Liao Z; Korte S; Shen J; Ding X; Hu Y; Kang Y; Keole SR; Sio TT; Wong WW; Sahoo N; Bues M; Liu W
Int J Radiat Oncol Biol Phys; 2018 Jun; 101(2):479-489. PubMed ID: 29550033
[TBL] [Abstract][Full Text] [Related]
27. Use of lung treatment plans to evaluate DIR algorithms.
Jurkovic IA; Stathakis S; Li Y; Patel A; Vincent J; Papanikolaou N; Mavroidis P
Australas Phys Eng Sci Med; 2018 Dec; 41(4):837-845. PubMed ID: 30144019
[TBL] [Abstract][Full Text] [Related]
28. Radiobiological impact of dose calculation algorithms on biologically optimized IMRT lung stereotactic body radiation therapy plans.
Liang X; Penagaricano J; Zheng D; Morrill S; Zhang X; Corry P; Griffin RJ; Han EY; Hardee M; Ratanatharathom V
Radiat Oncol; 2016 Jan; 11():10. PubMed ID: 26800883
[TBL] [Abstract][Full Text] [Related]
29. Voxel-Level BED Corrected Dosimetric and Radiobiological Assessment of 2 Kinds of Hybrid Radiotherapy Planning Methods for Stage III NSCLC.
Wang H; Huang Y; Chen H; Shao Y; Duan Y; Feng A; Gu H; Ma X; Xu Z; Kong Q; Zhou Y
Technol Cancer Res Treat; 2022; 21():15330338221107966. PubMed ID: 35731648
[No Abstract] [Full Text] [Related]
30. Combining advanced radiotherapy technologies to maximize safety and tumor control probability in stage III non-small cell lung cancer.
Guckenberger M; Kavanagh A; Partridge M
Strahlenther Onkol; 2012 Oct; 188(10):894-900. PubMed ID: 22933031
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of 4-dimensional computed tomography to 4-dimensional cone-beam computed tomography deformable image registration for lung cancer adaptive radiation therapy.
Balik S; Weiss E; Jan N; Roman N; Sleeman WC; Fatyga M; Christensen GE; Zhang C; Murphy MJ; Lu J; Keall P; Williamson JF; Hugo GD
Int J Radiat Oncol Biol Phys; 2013 Jun; 86(2):372-9. PubMed ID: 23462422
[TBL] [Abstract][Full Text] [Related]
32. Simulation of dosimetry impact of 4DCT uncertainty in 4D dose calculation for lung SBRT.
Liu G; Hu F; Ding X; Li X; Shao Q; Wang Y; Yang J; Quan H
Radiat Oncol; 2019 Jan; 14(1):1. PubMed ID: 30621744
[TBL] [Abstract][Full Text] [Related]
33. Dosimetric Comparison of Real-Time MRI-Guided Tri-Cobalt-60 Versus Linear Accelerator-Based Stereotactic Body Radiation Therapy Lung Cancer Plans.
Wojcieszynski AP; Hill PM; Rosenberg SA; Hullett CR; Labby ZE; Paliwal B; Geurts MW; Bayliss RA; Bayouth JE; Harari PM; Bassetti MF; Baschnagel AM
Technol Cancer Res Treat; 2017 Jun; 16(3):366-372. PubMed ID: 28168936
[TBL] [Abstract][Full Text] [Related]
34. Dosimetric impact of breathing motion in lung stereotactic body radiotherapy treatment using intensity modulated radiotherapy and volumetric modulated arc therapy [corrected].
Rao M; Wu J; Cao D; Wong T; Mehta V; Shepard D; Ye J
Int J Radiat Oncol Biol Phys; 2012 Jun; 83(2):e251-6. PubMed ID: 22365622
[TBL] [Abstract][Full Text] [Related]
35. An isotoxic planning comparison study for stage II-III non-small cell lung cancer: is intensity-modulated radiotherapy the answer?
Warren M; Webster G; Ryder D; Rowbottom C; Faivre-Finn C
Clin Oncol (R Coll Radiol); 2014 Aug; 26(8):461-7. PubMed ID: 24793504
[TBL] [Abstract][Full Text] [Related]
36. Toxicity and dosimetric analysis of non-small cell lung cancer patients undergoing radiotherapy with 4DCT and image-guided intensity modulated radiotherapy: a regional centre's experience.
Livingston GC; Last AJ; Shakespeare TP; Dwyer PM; Westhuyzen J; McKay MJ; Connors L; Leader S; Greenham S
J Med Radiat Sci; 2016 Sep; 63(3):170-8. PubMed ID: 27648281
[TBL] [Abstract][Full Text] [Related]
37. Impact of intensity-modulated radiation therapy as a boost treatment on the lung-dose distributions for non-small-cell lung cancer.
Choi Y; Kim JK; Lee HS; Hur WJ; Chai GY; Kang KM
Int J Radiat Oncol Biol Phys; 2005 Nov; 63(3):683-9. PubMed ID: 15927412
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of the clinical impact of the differences between planned and delivered dose in prostate cancer radiotherapy based on CT-on-rails IGRT and patient-reported outcome scores.
Hammers J; Lindsay D; Narayanasamy G; Sud S; Tan X; Dooley J; Marks LB; Chen RC; Das SK; Mavroidis P
J Appl Clin Med Phys; 2023 Jan; 24(1):e13780. PubMed ID: 36087039
[TBL] [Abstract][Full Text] [Related]
39. Intensity-modulated proton and carbon-ion radiotherapy using a fixed-beam system for locally advanced lung cancer: dosimetric comparison with x-ray radiotherapy and normal tissue complication probability (NTCP) evaluation.
Ming X; Mao J; Ma N; Chen J; Wang W; Sheng Y; Wu K
Phys Med Biol; 2024 Jan; 69(1):. PubMed ID: 38064747
[No Abstract] [Full Text] [Related]
40. Setting up a lung stereotactic body radiotherapy service in a tertiary center in Eastern India: The process, quality assurance, and early experience.
Shrimali RK; Saha A; Arun B; Prasath S; Nallathambi C; Bhoumik S; Mallick I; Achari RB; Chatterjee S
J Cancer Res Ther; 2020; 16(4):888-899. PubMed ID: 32930136
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]